Proinsulin C-peptide prevents type-1 diabetes-induced decrease of renal Na+-K+-ATPase α1-subunit in rats

Diabetes/Metabolism Research and Reviews

Volumn 26, Issue 3, 2010, Pages 193-199

  Nordquist, Lina ^a,b   Shimada, Kohei ^a   Ishii, Tatsuya ^a   Furuya, Daniela Tomie ^a   Kamikawa, Akihiro ^a   Kimura, Kazuhiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

C peptide; Diabetes mellitus; Tubular sodium transport

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); C PEPTIDE; INSULIN; SODIUM POTASSIUM ADENOSINE TRIPHOSPHATASE ALPHA1; SODIUM POTASSIUM ADENOSINE TRIPHOSPHATASE ALPHA2; SODIUM POTASSIUM ADENOSINE TRIPHOSPHATASE BETA3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GLOMERULUS; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY; KIDNEY COLLECTING TUBULE; KIDNEY DISTAL TUBULE; KIDNEY MEDULLA; KIDNEY PROXIMAL TUBULE; MALE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STOMACH PARIETAL CELL;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; INSULIN; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 77952334871     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1071     Document Type: Article

References (46)

1. Wojcikowski C, Maier V, Dominiak K, Fussganger R, Pfeiffer EF. Effects of synthetic rat C-peptide in normal and diabetic rats. Diabetologia 1983; 25: 288-290. (Pubitemid 13002129)
2. Wahren J. C-peptideNew findings and therapeutic implications in diabetes. Clin Physiol Funct Imaging 2004; 24: 180-189. (Pubitemid 39089034)
3. Sima AAF, Kamiya H, Li ZG. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. Eur J Pharmacol 2004; 490: 187-197.
4. Bruemmer D. C-peptide in insulin resistance and vascular complications: teaching an old dog new tricks. Circ Res 2006; 99: 1149-1151. (Pubitemid 44808648)
5. Rebsomen L, Khammar A, RaccahD, TsimaratosM. C-Peptide effects on renal physiology and diabetes. Exp Diabetes Res 2008; article ID: 281536.
6. Johansson BL, Sjoberg S, Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 1992; 35: 121-128.
7. Johansson BL, Kernell A, Sjoberg S, Wahren J. Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 1993; 77: 976-981. (Pubitemid 23301473)
8. Sjoquist M, Huang W, Johansson BL. Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int 1998; 54: 758-764. (Pubitemid 28397393)
9. Huang D-Y, Richter K, Breidenbach A, Vallon V. Human Cpeptide acutely lowers glomerular hyperfiltration and proteinuria in diabetic ratsa dose-response study. Naunyn Schmiedebergs Arch Pharmacol 2002; 365: 67-73. (Pubitemid 34045241)
10. Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Sjoquist M. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int 2001; 60: 1258-1265. (Pubitemid 32960021)
11. Samnegard B, Jacobson SH, Jaremko G, et al. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats. Nephrol Dial Transplant 2005; 20: 532-538. (Pubitemid 40378421)
12. Nordquist L, Moe E, Sjoquist M. The C-peptide fragment EVARQ reduces glomerular hyperfiltration in streptozotocin-induced diabetic rats. Diabetes Metab Res Rev 2007; 23: 400-405. (Pubitemid 47091244)
13. Katz AI, Epstein FH. The role of sodium-potassium-activated adenosine triphosphatase in the reabsorption of sodium by the kidney. Eur J Clin Invest 1967; 46: 1999-2011.
14. Ido Y, Vindigni A, Chang K, et al. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 1997; 277: 563-566. (Pubitemid 27369004)
15. Sima AA, Zhang W, Sugimoto K, et al. C-peptide prevents and improves chronic Type 1 diabetic polyneuropathy in the BB/Wor rat. Diabetologia 2001; 44: 889-897. (Pubitemid 32642462)
16. +-ATPase activity in diabetes mellitus type 1. Clin Sci 2000; 98: 283-290.
17. +-ATPase activity and diabetes: relationship with C-peptide level. Diabetologia 1998; 41: 1080-1084.
18. Kunt T, Schneider S, Pfützner A, et al. The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type 1 diabetes mellitus. Diabetologia 1999; 42: 465-471. (Pubitemid 29148406)
19. +-ATPase activity. Pflugers Arch 1984; 401: 97-100.
20. +- ATPase isoforms in heart, skeletal muscle, and kidney of diabetic rats. Am J Physiol 1993; 265: E243-E251.
21. +-ATPase activity in red blood cells, peripheral nerve and kidney. Diabetes Metab 1994; 20: 271-274.
22. +-ATPase activity in diabetic rats. J Nutr 2001; 131: 3160-3165.
23. Tsimarato M, Coste TC, Djemli-Shipkolye A, et al. Evidence of time-dependent changes in renal medullary Na,K-ATPase activity and expression in diabetic rats. Cell Mol Biol 2001; 47: 239-245.
24. +-ATPase via activation of ERK1/2 MAP kinases in human renal tubular cells. Cell Mol Life Sci 2004; 61: 2782-2790.
25. +-ATPase activity via PKC alpha in rat medullary thick ascending limb. Diabetologia 2003; 46: 124-131.
26. +-ATPase activity in synergism with neuropeptide Y. Diabetologia 1996; 39: 199-205.
27. +-ATPase activity of renal tubule segments. Diabetologia 1998; 41: 287-291.
28. Kamikawa A, Ishii T, Shimada K, et al. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats. Diabetes Metab Res Rev 2008; 24: 331-338. (Pubitemid 351802799)
29. +-ATPase in rat kidney. Am J Physiol 1993; 265: F792-F801.
30. Kitamura T, Kimura K, Jung BD, et al. Proinsulin C-peptide activates CRE binding proteins through the p38 MAP kinase pathway in mouse lung capillary endothelial cells. Biochem J 2002; 366: 737-744.
31. Kitamura T, Kimura K, Makondo K, et al. Proinsulin C-peptide increases nitric oxide production through mitogen-activated protein kinase-dependent transcriptional enhancement of endothelial nitric oxide synthase in rat aortic endothelial cells. Diabetologia 2003; 46: 1698-1705.
32. Maestroni A, Ruggieri D, Dell'Antonio G, Luzi L, Zerbini G. C-peptide increases the expression of vasopressin-activated calcium-mobilizing receptor gene through a G protein-dependent pathway. Eur J Endocrinol 2005; 152: 135-141.
33. Burnatowska-Hledin M, Zhao P, Capps B, et al. VACM-1, a cullin gene family member, regulates cellular signaling. Am J Physiol Cell Physiol 2000; 279: C266-C273.
34. Burnatowska-Hledin M, Lazdins IB, Listenberger L, et al. VACM- 1 receptor is specifically expressed in rabbit vascular endothelium and renal collecting tubule. Am J Physiol 1999; 276: F199-F209.
35. Djelidi S, Fay M, Cluzeaud F, et al. Transcriptional regulation of sodium transport by vasopressin in renal cells. J Biol Chem1997; 272: 32919-32924.
36. Blot-Chabaud M, Djelidi S, Courtois-Coutry N, et al. Coordinate control of Na, K-atpase mRNA expression by aldosterone, vasopressin and cell sodium delivery in the cortical collecting duct. Cell Mol Biol 2001; 47: 247-253.
37. +-ATPase a1-subunit gene in an MTAL cell line. Am J Physiol 1999; 276: F614-F621.
38. Féraille E, Béguin P, Carranza ML, et al. Is phosphorylation of the a1 subunit at Ser-16 involved in the control of Na, K-ATPase activity by phorbol ester-activated protein kinase C? Mol Biol Cell 2000; 11: 39-50.
39. Lecuona E, Dada LA, Sun H, et al. Na, K-ATPase a1-subunit dephosphorylation by protein phosphatase 2A is necessary for its recruitment to the plasma membrane. FASEB J 2006; 20: E2146-E2155.
40. Grunberger G, Qiang X, Li Z, et al. Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia 2001; 44: 1247-1257.
41. Li Z, Qiang X, Sima AA, Grunberger G. C-peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts. Biochem Biophys Res Commun 2001; 280: 615-619.
42. Kitamura T, Kimura K, Jung BD, et al. Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss 3T3 fibroblastsrequirement of protein kinase C, phosphoinositide 3-kinase and pertussis toxin-sensitive G protein. Biochem J 2001; 355: 123-129.
43. Rigler R, Pramanik A, Jonasson P, et al. Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci U S A 1999; 96: 13318-13323.
44. Geering K. Functional roles of Na,K-ATPase subunits. Curr Opin Nephrol Hypertens 2008; 17: 526-532.
45. MalikN, CanfieldVA, BeckersMC, GrosP, LevensonR. Identification of the mammalian Na,K-ATPase 3 subunit. J Biol Chem 1996; 271: 22754-22758.
46. Pierre S, Compe E, Grillasca JP, et al. RT-PCR detection of Na,KATPase subunit isoforms in human umbilical vein endothelial cells (HUVEC)evidence for the presence of alpha1 and beta3. Cell Mol Biol 2001; 47: 319-324.